Related Experiment Video

Updated: May 25, 2026

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies
09:03

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies

Published on: June 30, 2023

Anti-angiogenic properties of ADAMTS-4 in vitro

Yi-Ping Hsu1, Carolyn A Staton, Neil Cross

  • 1Academic Unit of Molecular Medicine and Rheumatology, University of Sheffield Medical School, Sheffield, UK.

International Journal of Experimental Pathology
|January 24, 2012
PubMed

Insights

ADAMTS-4, a proteinase, is expressed by endothelial cells and binds to vascular endothelial growth factor (VEGF). This suggests ADAMTS-4 may be a novel anti-angiogenic molecule, inhibiting key processes in blood vessel formation.

Area of Science:

  • Molecular biology
  • Cell biology
  • Biochemistry

Background:

  • Angiogenesis is crucial for development and diseases like cancer.
  • Vascular endothelial growth factor (VEGF) is a key stimulator of angiogenesis.
  • A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) proteins are involved in various biological processes, with some exhibiting anti-angiogenic properties.

Purpose of the Study:

  • To investigate the role of ADAMTS-4 in angiogenesis.
  • To determine if ADAMTS-4 interacts with VEGF and affects endothelial cell function.

Main Methods:

  • Expression analysis of ADAMTS-4 in endothelial cells.
  • VEGF binding assays for ADAMTS-4.
  • Assessment of endothelial cell phosphorylation, differentiation, and migration in response to VEGF and ADAMTS-4.

Main Results:

  • ADAMTS-4 is expressed by endothelial cells and binds to VEGF.
  • ADAMTS-4 inhibits VEGF-stimulated phosphorylation of VEGFR2.
  • ADAMTS-4 suppresses endothelial cell differentiation and migration.

Conclusions:

  • ADAMTS-4 exhibits anti-angiogenic properties.
  • ADAMTS-4 represents a potential therapeutic target for controlling aberrant angiogenesis.

More Related Videos

Rat Mesentery Angiogenesis Assay18:30

Rat Mesentery Angiogenesis Assay

Published on: June 18, 2011

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells09:03

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

Related Concept Videos

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...